[
  {
    "ts": null,
    "headline": "Davis Opportunity Fund 2025 Semi-Annual Review",
    "summary": "Davis Opportunity Fund returned 9.50% in the first six months of 2025, outperforming its benchmark. Read more here.",
    "url": "https://finnhub.io/api/news?id=c43f682b546edff03d51993ad7be9c63452e6b07c24299515e88d74f14866313",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754951400,
      "headline": "Davis Opportunity Fund 2025 Semi-Annual Review",
      "id": 136313722,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1072593728/image_1072593728.jpg?io=getty-c-w1536",
      "related": "CI",
      "source": "SeekingAlpha",
      "summary": "Davis Opportunity Fund returned 9.50% in the first six months of 2025, outperforming its benchmark. Read more here.",
      "url": "https://finnhub.io/api/news?id=c43f682b546edff03d51993ad7be9c63452e6b07c24299515e88d74f14866313"
    }
  },
  {
    "ts": null,
    "headline": "Tracking Christopher Davis' Davis Selected Advisers 13F Portfolio - Q2 2025 Update",
    "summary": "Tracking Christopher Davis' Davis Selected Advisers 13F Portfolio - Q2 2025 Update",
    "url": "https://finnhub.io/api/news?id=e9dde0be3e9c7edcc68fc9bce5951677a5ebb9247eb1fd21f8fade3db1768f8f",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754943475,
      "headline": "Tracking Christopher Davis' Davis Selected Advisers 13F Portfolio - Q2 2025 Update",
      "id": 136313089,
      "image": "",
      "related": "CI",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=e9dde0be3e9c7edcc68fc9bce5951677a5ebb9247eb1fd21f8fade3db1768f8f"
    }
  },
  {
    "ts": null,
    "headline": "Clover Health: Short-Term Pain Hides Its Long-Term Profitability Potential",
    "summary": "Clover Health's tech-driven model faces short-term challenges but holds strong upside potential. Explore why analysts predict 118% growth by 2026.",
    "url": "https://finnhub.io/api/news?id=619b07a243e66c4f16876f2e54eaf7eb003b6a801bb570c1c702f3b09c437f9b",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754908144,
      "headline": "Clover Health: Short-Term Pain Hides Its Long-Term Profitability Potential",
      "id": 136294621,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1305496188/image_1305496188.jpg?io=getty-c-w1536",
      "related": "CI",
      "source": "SeekingAlpha",
      "summary": "Clover Health's tech-driven model faces short-term challenges but holds strong upside potential. Explore why analysts predict 118% growth by 2026.",
      "url": "https://finnhub.io/api/news?id=619b07a243e66c4f16876f2e54eaf7eb003b6a801bb570c1c702f3b09c437f9b"
    }
  }
]